New diabetes clinical trial: A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in India
Published on: November 06, 2019 at 10:30PM
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Insulin Glargine
Sponsor: Eli Lilly and Company
Not yet recruiting
https://ift.tt/2CkT8Hb
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Insulin Glargine
Sponsor: Eli Lilly and Company
Not yet recruiting
https://ift.tt/2CkT8Hb
0 Comments